NYSTOP Drug Patent Profile
When do Nystop patents expire, and what generic alternatives are available?
Nystop is a drug marketed by Padagis Us and is included in one NDA.
The generic ingredient in NYSTOP is nystatin. There is one drug master file entry for this compound. Forty suppliers are listed for this compound. Additional details are available on the nystatin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Nystop
A generic version of NYSTOP was approved as nystatin by FOUGERA PHARMS on September 23rd, 1982.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for NYSTOP?
- What are the global sales for NYSTOP?
- What is Average Wholesale Price for NYSTOP?
Summary for NYSTOP
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 21 |
| Patent Applications: | 131 |
| Drug Prices: | Drug price information for NYSTOP |
| Drug Sales Revenues: | Drug sales revenues for NYSTOP |
| DailyMed Link: | NYSTOP at DailyMed |
Pharmacology for NYSTOP
| Drug Class | Polyene Antifungal |
US Patents and Regulatory Information for NYSTOP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Padagis Us | NYSTOP | nystatin | POWDER;TOPICAL | 064118-001 | Aug 16, 1996 | AT | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
